REVOLAX™ Deep with Lidocaine (1 x 1.1 mL) | Across

Short Description

A high-viscoelasticity, monophasic Hyaluronic Acid dermal filler formulated with 24 mg/mL of cross-linked HA and 0.3% lidocaine. Calibrated for mid-to-deep dermal and subcutaneous placement, REVOLAX™ Deep is engineered to treat deep facial depressions, correct severe nasolabial folds, sculpt chin and cheek contours, and perform structural lip augmentation with crisp projection and shape retention lasting 12 to 18 months.

Detailed Description

REVOLAX™ Deep with Lidocaine is an advanced, sterile, non-pyrogenic physiological cross-linked sodium hyaluronate injectable manufactured by Across Co., Ltd. (South Korea). Formulated with pure, non-animal-derived hyaluronic acid through bacterial fermentation, it is recognized for its dense, regular monophasic lattice structure.

Unlike traditional biphasic fillers containing suspended particles, REVOLAX Deep consists of an evenly cross-linked 3D hydrogel matrix that yields a high elastic modulus ($G’$) and low phase angle. This rheological profile provides high mechanical resistance against compressive forces from dynamic facial muscles, preventing gel migration, flattening, or lateral dispersion. At the same time, its uniform lattice pattern ensures a smooth, consistent extrusion force through fine-gauge needles, integrating into deep dermal planes without nodule formation or contour irregularities.

Treatment Areas & Indications

• Deep Facial Folds & Depressions:

  • Severe nasolabial folds (deep laugh lines running from the nasal ala to the oral commissures)

  • Pronounced marionette lines and downward oral commissures

  • Deep labiomental groove (crease between the lower lip and chin)

• Lip Sculpting & Structural Augmentation:

  • High-definition lip augmentation (ideal for Russian lip techniques requiring sharp vertical borders)

  • Crisp vermilion border definition and Cupid’s bow contouring

  • Full mucosal plumping with firm structural support

• Facial Contouring & Remodeling:

  • Malar and cheekbone augmentation

  • Chin projection and elongation (mild-to-moderate retrognathia correction)

  • Mandibular angle sharpening and jawline border definition

• Non-Surgical Rhinoplasty:

  • Nasal bridge straightening and dorsal elevation

Key Clinical Advantages

• Monophasic Regular Lattice Network: Formulated with an evenly cross-linked, dense polymer structure that provides uniform consistency, reducing post-injection lumps and surface unevenness.

• High Elasticity ($G’$) & Projection: Generates high resistance to tissue compression and muscle movement, holding crisp vertical projection in high-tension areas like the chin and lips without lateral spreading.

• Ultra-Low BDDE Residue: Undergoes a stringent dialysis purification process that strips unreacted cross-linker monomers to virtually non-detectable levels, minimizing the incidence of post-treatment edema, hypersensitivity, and erythema.

• 10% Volume Advantage (1.1 mL Syringe): Packed in a 1.1 mL pre-filled syringe format, offering 10% more product than standard 1.0 mL industry alternatives for more complete facial coverage.

• Integrated 0.3% Lidocaine: Infused with lidocaine hydrochloride to reduce procedural pain during needle or cannula extrusion, ensuring high patient comfort throughout mid-to-deep injections.

• Extended Clinical Longevity: Highly resistant to endogenous hyaluronidase breakdown and free-radical shear, sustaining structural correction for 12 to 18 months.

Technical Specifications

Professional Advisory: REVOLAX™ Deep with Lidocaine is a prescription-grade medical injectable intended strictly for certified dermatologists, plastic surgeons, and credentialed aesthetic physicians skilled in deep dermal volumizing and advanced lip sculpting techniques. Not intended for superficial dermal application or direct consumer use.